Olive oil helps lower inflammation in the body. This effect is stronger in people who already have heart disease or metabolic syndrome (a group of conditions like high blood pressure and high blood sugar) than in healthy people. So olive oil is especially helpful for those at higher risk.
See the scientific wording
Consumption of olive oil has a greater beneficial effect on inflammatory markers, such as high-sensitivity C-reactive protein (hs-CRP), in individuals with established metabolic syndrome or cardiovascular disease than in healthy individuals, indicating a potential therapeutic role for olive oil in these high-risk populations.
Indication only — weak evidence
One low-scoring study points this way, but the evidence is still early.
What the research says
1 study reviewedSupporting (1)
Systematic Review With Meta-AnalysisMeta-analysis2019
The study found that hs-CRP decreased in all but one study after high-polyphenol olive oil intervention, with the largest reductions observed in patients with metabolic syndrome or cardiovascular disease. This suggests that the anti-inflammatory effects of olive oil are most pronounced in individuals with elevated baseline inflammation, which is characteristic of these chronic conditions.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Olive oil contains special plant chemicals called polyphenols. These chemicals help the body in several ways. They tell the liver to make more 'good' cholesterol (HDL), which helps clean up bad cholesterol and reduces inflammation. They also calm down the immune system's alarm signals, so the liver makes less of a protein called CRP that is a marker of inflammation. In people who already have health problems like diabetes or heart disease, their body is more inflamed, so these calming effects are stronger, and the drop in CRP is bigger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Olive oil helps lower inflammation in the body. This effect is stronger in people who already have heart disease or metabolic syndrome (a group of conditions like high blood pressure and high blood sugar) than in healthy people. So olive oil is especially helpful for those at higher risk.
Mechanism
1 studyOlive oil polyphenols help the body in two main ways: they increase good cholesterol and calm down the immune system's inflammation signals. This leads to less CRP in the blood. In people who already have health problems, their body is more inflamed, so these effects are stronger and the CRP drop is bigger.
Olive oil contains special plant chemicals called polyphenols. These chemicals help the body in several ways. They tell the liver to make more 'good' cholesterol (HDL), which helps clean up bad cholesterol and reduces inflammation. They also calm down the immune system's alarm signals, so the liver makes less of a protein called CRP that is a marker of inflammation. In people who already have health problems like diabetes or heart disease, their body is more inflamed, so these calming effects are stronger, and the drop in CRP is bigger.
Polyphenols from olive oil are absorbed and activate nuclear receptors (e.g., PPARs) in the liver and intestine, upregulating genes involved in HDL metabolism and reverse cholesterol transport.
Increased HDL levels enhance reverse cholesterol transport and reduce oxidized LDL, which lowers vascular inflammation.
Polyphenols inhibit NF-kB signaling in immune cells, reducing the production of pro-inflammatory cytokines.
Reduced pro-inflammatory cytokines lead to decreased hepatic synthesis of acute-phase proteins, including CRP.
In states of chronic inflammation, the inflammatory signaling pathways are more active, so the inhibitory effect of polyphenols results in a larger reduction in CRP.
Less supported by current evidence, but not ruled out
The fat part of olive oil, especially oleic acid, can change how the body handles fats. It may lower triglycerides, which are a type of fat in the blood. Lower triglycerides can reduce inflammation, but this effect is not as strong as the polyphenol effect.
Oleic acid and other fatty acids are absorbed and incorporated into chylomicrons.
These fatty acids influence hepatic triglyceride synthesis or lipoprotein lipase activity, affecting triglyceride clearance.
Altered circulating triglyceride levels may reduce systemic inflammation indirectly.
Polyphenols may protect the cells that make insulin and help the body use insulin better. This can lower blood sugar and reduce inflammation, but this effect is not directly measured in the studies.
Polyphenols reduce inflammation in pancreatic tissue, protecting beta cells.
This preserves beta-cell function and enhances insulin secretion.
Improved insulin secretion leads to better glucose control, which reduces inflammatory stress.
Evidence from Studies
Supporting (1)
Community contributions welcome
Network Meta-Analysis of Metabolic Effects of Olive-Oil in Humans Shows the Importance of Olive Oil Consumption With Moderate Polyphenol Levels as Part of the Mediterranean Diet
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Olive Oil vs Control on Inflammatory Markers in High-Risk vs Healthy Populations
A comprehensive search of databases for RCTs that compare olive oil (any form) to a control (e.g., other oils or usual diet) and measure inflammatory markers (e.g., hs-CRP) in both high-risk (metabolic syndrome or CVD) and healthy adults, with meta-analysis of subgroup effects.
Randomized, Double-Blind, Placebo-Controlled Trial of Olive Oil vs Placebo on hs-CRP Levels in Patients with Metabolic Syndrome vs Healthy Controls
A randomized, double-blind, placebo-controlled trial with two parallel groups: olive oil (e.g., 30 ml/day) vs placebo (e.g., sunflower oil) for 12 weeks, measuring hs-CRP and other inflammatory markers at baseline and end, in adults with metabolic syndrome and healthy adults, with subgroup analysis by group.
Prospective Cohort Study Examining Olive Oil Intake and Change in Inflammatory Markers in Individuals with and without Cardiovascular Disease
A prospective cohort of adults with and without metabolic syndrome or CVD, with baseline dietary assessment (e.g., food frequency questionnaire) and repeated measurements of hs-CRP over several years, adjusting for confounders and comparing effect sizes between groups.
Case-Control Study Comparing Olive Oil Consumption and Inflammatory Marker Levels in Cases with Metabolic Syndrome vs Controls
A case-control study where cases are adults with metabolic syndrome or CVD and controls are healthy adults, matched on age and sex, with retrospective assessment of olive oil intake (e.g., validated questionnaire) and measurement of hs-CRP levels, comparing odds of high olive oil intake between groups.
Cross-Sectional Study of Olive Oil Intake and hs-CRP Levels in Adults with and without Metabolic Syndrome
A cross-sectional survey of a representative sample of adults, with dietary assessment (e.g., 24-hour recall or FFQ) and measurement of hs-CRP, comparing the association between olive oil intake and hs-CRP levels in those with and without metabolic syndrome or CVD, adjusting for confounders.